Avantax Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$467K	Buy	+6,358	New	+$467K	﹤0.01%	1619
2025 Q1	–	Sell	-5,821	Closed	-$293K	–	2245
2024 Q4	$293K	Buy	+5,821	New	+$293K	﹤0.01%	1793